Vitamin E / Risk Cancer Research Results

VitE, Vitamin E: Click to Expand ⟱

Features:

Vitamin E (VitE) = fat-soluble antioxidant family (tocopherols: α-, β-, γ-, δ-; tocotrienols: α-, β-, γ-, δ-), from diet (vegetable oils, nuts/seeds) and supplements (commonly α-tocopherol).
Primary mechanisms (conceptual rank):
1) Lipid-peroxidation chain-breaking antioxidant → ↓ membrane oxidative damage / ↓ lipid-ROS (anti-ferroptotic bias).
2) Redox-signaling modulation (secondary): alters ROS-triggered stress pathways (NF-κB, MAPK), inflammation tone.
3) Gene-regulatory adaptation: shifts antioxidant/stress programs (incl. NRF2 axis; context can be protective in normal tissues yet pro-survival in tumors).
4) Isoform-dependent anti-cancer signaling (notably tocotrienols): apoptosis/anti-proliferation, membrane/ER stress effects (model-dependent).
PK / bioavailability: absorption is fat-dependent; circulating levels rise modestly vs many in-vitro study doses; isoforms differ (tocotrienols often have distinct kinetics vs αT).
In-vitro vs systemic exposure: many cell studies use ≥10–100 µM or high bolus conditions that commonly exceed achievable free plasma/tissue levels from typical oral dosing (esp. for non-α isoforms).
Clinical evidence status: cancer prevention data are mixed and isoform-specific; high-dose αT (e.g., 400 IU/d) showed harm in prostate cancer risk (SELECT). Evidence is not “anti-cancer RCT–proven” and is best framed as context-/isoform-dependent with meaningful clinical constraints.

It primarily comprises two families:
Tocopherols
α-Tocopherol (most active and abundant form found in human tissues)
β-Tocopherol
γ-Tocopherol
δ-Tocopherol
Tocotrienols
α-Tocotrienol
β-Tocotrienol
γ-Tocotrienol
δ-Tocotrienol

-Vitamin E can neutralize free radicals, which are reactive molecules that may damage cells and potentially contribute to cancer development. This antioxidant property has led researchers to explore whether vitamin E could help protect cells from damage during cancer treatment.
-Cancer Prevention: Some epidemiological studies suggested that higher intake of vitamin E (usually through diet rather than supplements) might be associated with a lower risk of certain cancers.

Vitamin E (VitE) — Cancer-Relevant Pathways (isoform- and context-dependent)

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	Lipid peroxidation / membrane protection	↓ (context-dependent)	↓	P	Antioxidant “chain-breaker” in membranes	Core pharmacology; can protect normal tissue but may also protect tumor cells from oxidative stress therapies (model-dependent).
2	ROS tone	↓ (context-/dose-dependent)	↓	P→R	↓ oxidative stress signaling	Often secondary to lipid radical scavenging; can blunt ROS-mediated cytotoxicity from chemo/radiation in some settings (context-dependent).
3	Ferroptosis axis (iron/lipid-ROS death)	↓ (anti-ferroptotic bias)	↓	P→R	Suppresses lipid-ROS propagation	Mechanistically coherent: VitE tends to oppose ferroptotic lipid peroxidation; may be undesirable where ferroptosis is leveraged therapeutically.
4	NRF2 antioxidant program	↑ (context-dependent)	↑	G	Adaptive antioxidant response	NRF2 can be tissue-protective in normal cells yet pro-survival / resistance-promoting in some tumors (context-dependent).
5	NF-κB / inflammatory signaling	↓ (model-dependent)	↓ (often)	R→G	Anti-inflammatory bias	Redox-linked; magnitude varies by isoform (αT vs γT vs tocotrienols) and stimulus.
6	Apoptosis / mitochondrial stress	↑ (tocotrienols & high concentration only)	↔ / ↓ (protective)	R→G	Pro-apoptotic signaling (select models)	Tocotrienols are more often reported pro-apoptotic vs αT; frequently requires supra-physiologic exposure (model-dependent).
7	Ca²⁺ handling (ER/mitochondrial stress coupling)	↔ (model-dependent)	↔	R	Stress-modulating cross-talk	Not a universal “signature axis” for VitE, but can matter when ER stress/mitochondrial dysfunction is the readout.
8	Clinical Translation Constraint	—	—	—	Prevention/adjunct limitations	Isoform + dose matter; high-dose αT (400 IU/d) increased prostate cancer risk in SELECT; in-vitro dosing often exceeds realistic systemic exposure.

TSF Legend: P: 0–30 min (direct redox/membrane effects) | R: 30 min–3 hr (acute stress signaling) | G: >3 hr (gene-regulatory adaptation)

Vitamin E (α-tocopherol) — Alzheimer’s Disease (AD) / Neuronal-Protection-Relevant Axes

Rank	Pathway / Axis	Cells (AD-relevant; mostly “normal” neurons/glia under stress)	TSF	Primary Effect	Notes / Interpretation
1	Lipid peroxidation / membrane oxidative injury	↓	P	Neuroprotective antioxidant (membrane)	Mechanistic fit to oxidative-stress hypothesis; strongest “core” axis for VitE in CNS stress contexts.
2	ROS tone	↓	P→R	↓ oxidative stress signaling	Often downstream of lipid radical scavenging; may reduce oxidative damage markers (model-dependent).
3	Neuroinflammation (NF-κB-linked)	↓ (model-dependent)	R→G	Anti-inflammatory bias	Magnitude depends on model and background diet/status.
4	Clinical evidence constraint	—	—	Mixed RCT outcomes by stage	MCI: 2000 IU/d VitE did not significantly delay progression to AD in a 3-year trial; mild–moderate AD: 2000 IU/d αT slowed functional decline vs placebo in TEAM-AD; earlier ADCS trial also reported slowed progression signals (stage-dependent).

TSF Legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr

Risk, Risk: Click to Expand ⟱

Source:

Type:

Risk: by definition reduces risk of disease or cancer.
Down Target direction of risk indicates lower cancer risk.
ChemoPreventive also mean lower cancer risk. But for Chemopreventive an up arrow indicates more preventive.

Cancer Risk Impact Score (CRIS)
CRIS scale:
–5 = very strong risk reduction
–4 = strong risk reduction
–3 = moderate risk reduction
–2 = modest risk reduction
–1 = weak / context-dependent
0 = neutral


CRIS  Exposure / Compound  Evidence  Cancers  Notes


-5  Exercise (overall)
VStrong Hum  BC, CRC, Endo, PCa, Liv
↓insulin/IGF-1, ↓inflammation, ↑immune surveillance, ↓hormones



-5  Aerobic + resistance  VStrong Hum  Broad inc + mort
Best overall exercise synergy



-4  Aerobic exercise (mod–vig)  VStrong Hum  BC, CRC, Endo
Dose–response; ↓visceral fat



-4  Resistance training (alone)  Strong Hum  BC, CRC
↑insulin sensitivity; ↑lean mass



-3  High-intensity interval training  Mod–Strong Hum  BC, CRC
↑AMPK; ↑mitochondrial function; adherence matters



-2  NEAT / low-intensity activity  Moderate Hum  CRC
↓sedentary harm



-5  Cruciferous vegetable pattern  Strong Hum  Lung, CRC, BC, PCa
↑NRF2, ↓CYP1; ITC synergy



-5  Sunlight exposure (physiologic)  Strong Hum  CRC, BC, PCa
↑circadian alignment, ↑immune effects beyond vitamin D



-4  Fasting (metabolic pattern)
Strong Mech + Hum  BC, CRC, PCa 
↓IGF-1, ↓mTOR, ↑autophagy



-4  Curcumin
Hum + Pre  GI, BC, PCa
↓NF-κB, ↓STAT3



-4  Sulforaphane
Hum + Pre  Lung, CRC, BC
↑NRF2, ↓HDAC



-4  PEITC
Hum + Pre  Lung, CRC, PCa
↓CYP1A2, ↑apoptosis



-4  EGCG (tea matrix)
Strong Hum  GI, PCa, BC
↓angiogenesis; tea matrix superior to extract



-4  Lycopene
Strong Hum  PCa
↓oxidative DNA damage



-4  Apigenin
Pre + Diet Hum  BC, PCa, CRC 
↓PI3K-AKT, ↑p53



-4  Luteolin
Pre + Diet Hum  Lung, CRC, BC 
↓STAT3, ↓EMT



-4  Kaempferol
Diet Hum  Ov, Panc, Lung
↓VEGF, ↑apoptosis



-4  Fisetin
Pre + Early Hum  CRC, PCa, Mel
↓mTOR; senolytic activity



-4  Ellagic acid → Urolithin A
Hum (microbiome)  CRC, PCa, BC
↑mitophagy, ↓ER/AR signaling



-3  Omega-3 (EPA/DHA)
Strong Hum  CRC, BC
↓inflammation, ↓COX-2



-3  Vitamin D3 (supp)
Obs + RCT  CRC, BC
U-shaped response; ↓proliferation



-3  Garlic (allicin)
Mod Hum  GI
↓inflammation, ↓H. pylori



-3  Mushroom beta-glucans
Hum adjunct  GI, BC
↑NK cells, ↑immune surveillance



-3  Melatonin
Hum + Mech  BC, PCa
↓estrogen signaling, ↑circadian regulation



-3  Coffee (whole)
Strong Hum  Liv, Endo
↓fibrosis, ↓inflammation



-2  Quercetin
Limited Hum  Lung, CRC
Senolytic; ↓PI3K signaling



-2  Resveratrol
Limited Hum  CRC, BC
↓NF-κB; low bioavailability



-2  I3C / DIM
Mod Hum  BC, Cerv
↑2-OH estrogen, ↓ER signaling



-2  Thymoquinone
Early Hum  BC, CRC
↑apoptosis, ↓NF-κB



-2  Beta-carotene (food)
Hum  Lung
Antioxidant only in whole-food context



-1  Vitamin K2 (MK-4/7)
Limited Hum  Liv, PCa
↓proliferation, ↑differentiation



-1  Boron
Obs  PCa, Lung
↓inflammation; hormone modulation



0  Vitamin C (oral)
Strong Hum  —
Neutral overall effect



0  Genistein (soy)
Strong Hum  BC, PCa
Timing-dependent effects



0  Selenium (diet)
Mixed Hum  PCa
Narrow therapeutic window



0  Capsaicin
Mixed  Gastric
Dose-dependent effects



+2  Vitamin E (alpha only)
Strong RCT  PCa
Increased risk signal



+2  Green tea extract (high-dose)
Case reports  Liv
Hepatotoxicity reported



+4  Beta-carotene (supplement)
Strong RCT  Lung (smokers)
Increased lung cancer risk in smokers



+5  Alcohol (ethanol)
Strong Hum  BC, Liv, Eso
Linear increase in cancer risk




Evidence
Hum        human data
VStrong    very strong
Strong     strong
Mod        moderate
Obs        observational
Pre        preclinical
RCT        randomized controlled trial
Mech       mechanistic
Adjunct    adjunct clinical use

Scientific Papers found: Click to Expand⟱

4076-

FA,

VitE,

VitB6,

Reduced risk of Alzheimer’s disease with high folate intake: The Baltimore Longitudinal Study of Aging

Study,

AD,

579 nondemented elderly volunteers

*Risk↓, *other↝, *Risk∅,

4077-

VitB6,

FA,

VitB12,

VitD3,

VitE

Vitamin Supplementation as an Adjuvant Treatment for Alzheimer’s Disease

Review,

AD,

*antiOx↑, *cognitive↑, *homoC↓, *Risk↓, *Risk↓, *Risk↓, *other↝, *Dose↝, *Risk↓, *Risk↓,

Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:

Total Targets: 0

Pathway results for Effect on Normal Cells:

Functional Outcomes ⓘ

cognitive↑, 1, Risk↓, 6, Risk∅, 1,
Total Targets: 7

Scientific Paper Hit Count for: Risk, Risk

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:307  Target#:785  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

Vitamin E / Risk Cancer Research Results

Vitamin E (VitE) — Cancer-Relevant Pathways (isoform- and context-dependent)

Vitamin E (α-tocopherol) — Alzheimer’s Disease (AD) / Neuronal-Protection-Relevant Axes

Pathway results for Effect on Cancer / Diseased Cells:

Pathway results for Effect on Normal Cells:

Redox & Oxidative Stress ⓘ

Core Metabolism/Glycolysis ⓘ

Transcription & Epigenetics ⓘ

Drug Metabolism & Resistance ⓘ

Functional Outcomes ⓘ

Home Page